2021
15
December
2021
|
09:54
Europe/London
TaBriX is a new spin-out company from The ¼â½ÐÊÓƵapp (UoM) with the mission to create novel anti-virulence drugs to fight difficult-to-treat infections. TaBriX’s initial focus is on the treatment of drug-resistant TB.
Read more
2019
19
March
2019
|
15:00
Europe/London
Around 1 in 15 people affected by tuberculosis are likely get the treatable fungal infection aspergillosis according to new research by experts at The ¼â½ÐÊÓƵapp and Gulu Referral Hospital, Uganda.
Read more
2018
11
September
2018
|
16:53
Europe/London
Scientists at The ¼â½ÐÊÓƵapp have developed the first non-antibiotic drug to successfully treat tuberculosis in animals.
Read more
2008
06
June
2008
|
01:00
Europe/London
Researchers at The ¼â½ÐÊÓƵapp are developing a new drug against tuberculosis (TB), one of the oldest human infectious diseases, which is now threatening to reach epidemic proportions once more.
TB poses a serious threat to all …
Read more
